BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced additional ...

BD invested $10 million last year to increase manufacturing capacity. The recent expansion has created more than 200 jobs.

BD, a global medical technology company, and Biosero, a developer of laboratory automation solutions, have joined forces to ...

Becton, Dickinson's stock momentum is improving, but geopolitical risks and global headwinds warrant caution. Click here to ...

BD operates more than 30 manufacturing and distribution facilities in the United States, which represent an important part of the backbone of the U.S. medical product supply chain. These ...

BD operates more than 30 manufacturing and distribution facilities in the United States, which represent an important part of the backbone of the U.S. medical product supply chain. These facilities ...

BD (NYSE: BDX) announced today that it plans to invest further in U.S. manufacturing to add capacity for certain critical ...

NYSE:BDX) BD and Biosero Collaborate to Enable Robotic Integration with Flow Cytometers Used in Drug Discovery and ...

FRANKLIN LAKES, N.J., Jan. 15, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology ... for ensuring a resilient supply of essential health ...

Becton, Dickinson and Co. is increasing its U.S. manufacturing capacity for essential medical devices, including syringes, needles and IV catheters.

Director-General of Health Patrick Amoth detailed the nationwide distribution plan, with Nairobi receiving the largest ...